|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Ethosuximide Capsules, 250 mg, Banner Pharmacaps ANDA 40-430 10/28/02
Ethosuximide Syrup,250 mg/5 mL, Pharmaceutical Associates, ANDA 40-253 Zarontin (ethosuximide) Capsules, Pfizer NDA 12-380/S29 4/19/02 5/2/02
Zarontin (ethosuximide) 250 mg Capsules and 250 mg/5 ml Syrup. Parket-Davis NDA 12380/S-22/23/25 ETHOSUXIMIDE Capsule; 250MG ETHOSUXIMIDE BANNER PHARMACAPS
012380 ETHOSUXIMIDE Capsule; 250MG ZARONTIN PARKE DAVIS
081306 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE Copley 080258 ETHOSUXIMIDE Syrup; 250MG/5ML ZARONTIN PARKE DAVIS
040253 ETHOSUXIMIDE Syrup; 250MG/5ML ETHOSUXIMIDE ASSOC | Zarontin Capsules, Pfizer, Labeling Supplement
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|